Although the United States federal government is coordinating the nation’s public health campaign against the COVID-19 coronavirus pandemic, the states—and the governors in particular—are coordinating across the country and party lines to implement containment plans using all the public and private tools at their disposal.
As the United States combats the COVID-19 coronavirus pandemic, federal agencies like the U.S. Food and Drug Administration’s (FDA’s) Oncology Center of Excellence (OCE) are reassuring specific populations, such as those in the cancer community, that the agency is still patient-centered in its mission.
On April 1, 2020, the U.S. Food and Drug Administration asked manufacturers to withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.
Chemotherapy is one of the most successful forms of cancer treatment available, but it’s frequently thought of as deadly and dangerous because of its hazardous chemical properties and potential for severe side effects in patients. What’s often left out of the chemotherapy conversation is the danger it poses to healthcare workers handling the hazardous medications. In two new articles published in the Oncology Nursing Forum, Oncology Nursing Society (ONS) member AnnMarie Walton, PhD, MPH, RN,
With almost daily public briefings, the White House is taking a more aggressive approach to communicating updates on the COVID-19 coronavirus to the American population.
“Desperate times breed desperate measures." —William Shakespeare
Today is an unprecedented time in history: the COVID-19 coronavirus has changed the world as we know it. The United States faces a challenge unlike anything we’ve ever experienced, especially on our soil. We will lose many lives. Living in New Rochelle, NY, has made me acutely aware of this, perhaps before many other parts of the country.
Although many federal health agencies are involved in the COVID-19 coronavirus pandemic, central to every discussion has been the Centers for Disease Control and Prevention (CDC). Charged with the safety of the American public’s health, CDC is spearheading the United States’ epidemiologic approach, including how healthcare workers should recognize, test for, report, and respond to the coronavirus.
Tara Schwetz, PhD, acting director of the National Institute of Nursing Research (NINR), issued a statement acknowledging the role of nurses as more essential than ever to patient care during the COVID-19 coronavirus pandemic.
As part of a larger understanding of the social determinants of health, geography—whether it’s rural or metropolitan, urban or suburban—plays a huge part in how patients understand, receive, and access care. Regardless of zip code, community, or travel distance, patients have a right to receive the best possible care for their cancer diagnosis. As staunch patient advocates, oncology nurses are primed to help patients navigate geographic disparities and overcome challenges they face in treatment.
A day after President Donald Trump was considering lifting some of the quarantine mandates, healthcare leaders from the American Hospital Association, American Medical Association and American Nurses Association (ANA) released an open letter urging Americans to stay home.